Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by BTIG Research from $340.00 to $350.00 in a research report released on Monday morning, The Fly reports. The firm currently has a buy rating on the medical instruments supplier’s stock. A number of other equities research analysts have also weighed in on the company. […]
Insulet (NASDAQ:PODD – Get Rating) had its price objective lifted by Stifel Nicolaus from $300.00 to $342.00 in a report published on Thursday, The Fly reports. The brokerage currently has a hold rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the company. Morgan Stanley boosted their target price on […]
Congress Wealth Management LLC DE increased its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,396 shares of the medical instruments supplier’s stock after purchasing an additional 624 shares during the […]
New York State Common Retirement Fund grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,353 shares of the medical instruments supplier’s stock after acquiring an additional 5,424 shares during the period. […]
Riverstone Advisors LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,087 shares of the medical instruments supplier’s stock after selling 1,086 shares during the quarter. Insulet accounts for 3.1% of Riverstone Advisors LLC’s investment portfolio, making the stock its […]